Literature DB >> 27411806

MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.

Neeraj Upadhyay1, Antonio Suppa1,2, Maria Cristina Piattella1, Matteo Bologna1,2, Flavio Di Stasio2, Alessandra Formica1, Francesca Tona1, Carlo Colosimo3, Alfredo Berardelli1,2, Patrizia Pantano4,5.   

Abstract

We evaluated MRI measures of gray and white matter damages in 19 patients with progressive supranuclear palsy (PSP), 11 with corticobasal syndrome (CBS), and 14 healthy subjects (HS) to differentiate patients with PSP from those with CBS. We calculated surface-based maps of the cortical volume, cortical thickness, surface area, and voxel level maps of sub-cortical volume, and diffusion tensor imaging parameters using automated scripts implemented in FreeSurfer and FSL toolboxes. No significant differences in cortical volume loss were observed between PSP and CBS. When cortical volume was divided into cortical thickness and surface area, cortical thickness in peri-rolandic brain regions was significantly smaller in CBS than in PSP patients, whereas surface area was significantly smaller in PSP than HS. We also found widespread volume loss in sub-cortical structures in patients with PSP and CBS in comparison to HS. Both patient groups displayed diffusion tensor imaging abnormalities: compared to HS, widespread fractional anisotropy and radial diffusivity changes were observed in PSP, whereas axial and radial diffusivity changes were prominent in CBS. Mini-mental state examination positively correlated with diffusion changes in patients with PSP. In conclusion, cortical thickness, surface area, and diffusion tensor imaging parameters may be sensitive enough to help differentiate patients with PSP from those with CBS.

Entities:  

Keywords:  Corticobasal syndrome; DTI parameters; Progressive supranuclear palsy; Surface-based morphometric measures

Mesh:

Year:  2016        PMID: 27411806     DOI: 10.1007/s00415-016-8224-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  44 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome.

Authors:  Naomi Kouri; Melissa E Murray; Anhar Hassan; Rosa Rademakers; Ryan J Uitti; Bradley F Boeve; Neill R Graff-Radford; Zbigniew K Wszolek; Irene Litvan; Keith A Josephs; Dennis W Dickson
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

3.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

4.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

5.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

6.  Head size, age and gender adjustment in MRI studies: a necessary nuisance?

Authors:  Josephine Barnes; Gerard R Ridgway; Jonathan Bartlett; Susie M D Henley; Manja Lehmann; Nicola Hobbs; Matthew J Clarkson; David G MacManus; Sebastien Ourselin; Nick C Fox
Journal:  Neuroimage       Date:  2010-06-16       Impact factor: 6.556

7.  Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Authors:  Giovanni Rizzo; Paolo Martinelli; David Manners; Cesa Scaglione; Caterina Tonon; Pietro Cortelli; Emil Malucelli; Sabina Capellari; Claudia Testa; Piero Parchi; Pasquale Montagna; Bruno Barbiroli; Raffaele Lodi
Journal:  Brain       Date:  2008-09-26       Impact factor: 13.501

8.  Insular atrophy and diminished disgust reactivity.

Authors:  Alice Verstaen; Janet A Eckart; Luma Muhtadie; Marcela C Otero; Virginia E Sturm; Claudia M Haase; Bruce L Miller; Robert W Levenson
Journal:  Emotion       Date:  2016-05-05

9.  Neuroimaging correlates of blinking abnormalities in patients with progressive supranuclear palsy.

Authors:  Matteo Bologna; Maria Cristina Piattella; Neeraj Upadhyay; Alessandra Formica; Antonella Conte; Carlo Colosimo; Patrizia Pantano; Alfredo Berardelli
Journal:  Mov Disord       Date:  2015-12-04       Impact factor: 10.338

10.  Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

Authors:  Amanda Worker; Camilla Blain; Jozef Jarosz; K Ray Chaudhuri; Gareth J Barker; Steven C R Williams; Richard Brown; P Nigel Leigh; Andrew Simmons
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

View more
  6 in total

1.  Dentatorubrothalamic tract reduction using fixel-based analysis in corticobasal syndrome.

Authors:  Shun Sakamoto; Takashi Kimura; Koji Kajiyama; Kumiko Ando; Masanaka Takeda; Hiroo Yoshikawa
Journal:  Neuroradiology       Date:  2020-09-29       Impact factor: 2.804

Review 2.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

3.  Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome.

Authors:  Komal Bharti; Matteo Bologna; Neeraj Upadhyay; Maria Cristina Piattella; Antonio Suppa; Nikolaos Petsas; Costanza Giannì; Francesca Tona; Alfredo Berardelli; Patrizia Pantano
Journal:  Front Neurol       Date:  2017-06-06       Impact factor: 4.003

4.  Disease-related patterns of in vivo pathology in Corticobasal syndrome.

Authors:  Flavia Niccolini; Heather Wilson; Stephanie Hirschbichler; Tayyabah Yousaf; Gennaro Pagano; Alexander Whittington; Silvia P Caminiti; Roberto Erro; Janice L Holton; Zane Jaunmuktane; Marcello Esposito; Davide Martino; Ali Abdul; Jan Passchier; Eugenii A Rabiner; Roger N Gunn; Kailash P Bhatia; Marios Politis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-08       Impact factor: 9.236

5.  18F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy.

Authors:  Nicolas Nicastro; Patricia Vazquez Rodriguez; Maura Malpetti; William Richard Bevan-Jones; P Simon Jones; Luca Passamonti; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  J Neurol       Date:  2019-10-22       Impact factor: 4.849

Review 6.  Neuropsychiatric disturbances in atypical parkinsonian disorders.

Authors:  Daniele Belvisi; Isabella Berardelli; Antonio Suppa; Andrea Fabbrini; Massimo Pasquini; Maurizio Pompili; Giovanni Fabbrini
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-09       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.